JP2017503024A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503024A5
JP2017503024A5 JP2016562455A JP2016562455A JP2017503024A5 JP 2017503024 A5 JP2017503024 A5 JP 2017503024A5 JP 2016562455 A JP2016562455 A JP 2016562455A JP 2016562455 A JP2016562455 A JP 2016562455A JP 2017503024 A5 JP2017503024 A5 JP 2017503024A5
Authority
JP
Japan
Prior art keywords
group
formula
member selected
cyano
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503024A (ja
JP6626454B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072291 external-priority patent/WO2015103060A1/en
Publication of JP2017503024A publication Critical patent/JP2017503024A/ja
Publication of JP2017503024A5 publication Critical patent/JP2017503024A5/ja
Application granted granted Critical
Publication of JP6626454B2 publication Critical patent/JP6626454B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562455A 2014-01-06 2014-12-23 Trpa1モジュレーター Active JP6626454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461924119P 2014-01-06 2014-01-06
US61/924,119 2014-01-06
PCT/US2014/072291 WO2015103060A1 (en) 2014-01-06 2014-12-23 Trpa1 modulators

Publications (3)

Publication Number Publication Date
JP2017503024A JP2017503024A (ja) 2017-01-26
JP2017503024A5 true JP2017503024A5 (https=) 2018-02-08
JP6626454B2 JP6626454B2 (ja) 2019-12-25

Family

ID=53493929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562455A Active JP6626454B2 (ja) 2014-01-06 2014-12-23 Trpa1モジュレーター

Country Status (10)

Country Link
US (2) US9951046B2 (https=)
EP (1) EP3092228A4 (https=)
JP (1) JP6626454B2 (https=)
CN (1) CN106061969B (https=)
AU (1) AU2014374043B2 (https=)
CA (1) CA2936111C (https=)
IL (1) IL246625B (https=)
SG (1) SG11201605559VA (https=)
WO (1) WO2015103060A1 (https=)
ZA (1) ZA201605332B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106061969B (zh) 2014-01-06 2019-10-29 阿尔戈么迪克斯有限公司 Trpa1调节剂
EP3381896B1 (en) * 2015-11-27 2023-01-18 Taiho Pharmaceutical Co., Ltd. Biphenyl compound or salt thereof
EP3481808A4 (en) * 2016-07-06 2020-07-15 Algomedix, Inc. TRPA1 ANTAGONISTS FOR THE TREATMENT OF DRY EYE SYNDROME, EYE PAIN AND INFLAMMATION
CN106580984A (zh) * 2016-12-12 2017-04-26 高群 一种治疗高血脂症的药物组合物
WO2018162607A1 (en) * 2017-03-07 2018-09-13 F. Hoffmann-La Roche Ag Oxadiazole transient receptor potential channel inhibitors
KR102361918B1 (ko) 2017-05-26 2022-02-14 다이호야쿠힌고교 가부시키가이샤 신규 비페닐 화합물 또는 그의 염
TWI770925B (zh) * 2017-05-26 2022-07-11 日商大鵬藥品工業股份有限公司 使用有新穎聯苯化合物之抗腫瘤效果增強劑
AU2018276611B2 (en) 2017-05-31 2022-01-06 Taiho Pharmaceutical Co., Ltd. Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1
CN109596818B (zh) * 2018-12-13 2024-03-19 丁蓉 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法
WO2021095835A1 (en) 2019-11-13 2021-05-20 Taiho Pharmaceutical Co., Ltd. Novel salt of terphenyl compound
JP7688339B2 (ja) * 2020-01-22 2025-06-04 国立研究開発法人理化学研究所 新規化合物、およびその利用
FR3114235A1 (fr) 2020-09-18 2022-03-25 Université Grenoble Alpes Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer
CN112694436B (zh) * 2020-12-30 2022-07-08 济南周行医药科技有限公司 一种槟榔碱的合成方法
IT202100015098A1 (it) 2021-06-09 2022-12-09 Flonext S R L Composto antagonista del canale trpa1 per uso in patologie degenerative della retina
KR20250091305A (ko) * 2022-11-10 2025-06-20 프라임 진 테라퓨틱스 컴퍼니 리미티드 질소 함유 스피로 고리 화합물, 약학 조성물 및 이의 용도
CN121735881A (zh) * 2026-02-27 2026-03-27 泰励生物科技(上海)有限公司 砜类化合物的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE49198T1 (de) * 1984-05-12 1990-01-15 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
GB8429128D0 (en) * 1984-11-17 1984-12-27 Fisons Plc Heterocyclic compounds
EP1019394A1 (en) * 1997-05-22 2000-07-19 G.D. Searle & Co. PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
EP1077971A1 (en) * 1998-05-14 2001-02-28 G.D. SEARLE & CO. 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
AU2004200420A1 (en) * 2003-03-11 2004-09-30 Astellas Pharma Inc. Inhibitor of cyclooxygenase
EP1620095A4 (en) * 2003-04-24 2009-04-01 Merck & Co Inc HEMMER OF ACT ACTIVITY
ES2297502T3 (es) 2003-10-23 2008-05-01 F. Hoffmann-La Roche Ag Derivados de triaza-espiropiperidinas para uso como inhibidores de glyt-1 en el tratamiento de trastornos neurologicos y neuropsiquiatricos.
CN1902191A (zh) * 2003-12-26 2007-01-24 第一制药株式会社 酰胺基吡唑衍生物
TW200526641A (en) * 2003-12-26 2005-08-16 Daiichi Seiyaku Co Amidopyrazole derivatives
GB0417910D0 (en) * 2004-08-11 2004-09-15 Novartis Ag Organic compounds
BRPI0612287A8 (pt) 2005-06-27 2019-01-22 Exelixis Inc composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear
AU2006327181A1 (en) 2005-12-22 2007-06-28 Hydra Biosciences, Inc. TRPA1 inhibitors for treating pain
US7977358B2 (en) 2007-07-26 2011-07-12 Hoffmann-La Roche Inc. Pyrazol derivatives
US8877784B2 (en) 2008-01-04 2014-11-04 Abbvie Inc. TRPA1 antagonists
WO2009147079A1 (en) 2008-06-02 2009-12-10 Janssen Pharmaceutica Nv 3,4-dihydropyrimidine trpa1 antagonists
WO2010125469A1 (en) * 2009-04-29 2010-11-04 Glenmark Pharmaceuticals, S.A. Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
CA2773713A1 (en) 2009-10-07 2011-04-14 Merck Sharp & Dohme Corp. Novel trpa1 antagonists
WO2012174362A1 (en) 2011-06-17 2012-12-20 Research Triangle Institute Pyrazole derivatives as cannabinoid receptor 1 antagonists
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
PT2903965T (pt) 2012-10-01 2017-06-06 Orion Corp Derivados de n-prop-2-inilcarboxamida e sua utilização como antagonistas de trpa1
CN106061969B (zh) 2014-01-06 2019-10-29 阿尔戈么迪克斯有限公司 Trpa1调节剂
EP3481808A4 (en) 2016-07-06 2020-07-15 Algomedix, Inc. TRPA1 ANTAGONISTS FOR THE TREATMENT OF DRY EYE SYNDROME, EYE PAIN AND INFLAMMATION

Similar Documents

Publication Publication Date Title
JP2017503024A5 (https=)
US12478609B2 (en) Combination therapies using immuno-DASH inhibitors and PGE2 antagonists
HRP20140919T1 (hr) Spojevi koji moduliraju androgene receptore
JP2012521428A5 (https=)
HRP20110456T1 (hr) Derivati indola kao agonisti receptora s1p1
HRP20211032T1 (hr) Postupci za uporabu agonista fxr
RU2014103587A (ru) Производные циклических аминов в качестве антагонистов рецептора ер4
JP2017518981A5 (https=)
JP2010511013A5 (https=)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
RU2010136974A (ru) Способы лечения воспалительной боли
JP2013523746A5 (https=)
JP2013521288A5 (https=)
JP2017505293A5 (https=)
MA30704B1 (fr) Compositions therapeutiques
JP2021530513A5 (https=)
RU2010102990A (ru) Производные оксадиазолов в качестве ингибиторов dgat
US20230372372A1 (en) Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists
JP2022521955A5 (https=)
JP2020505354A5 (https=)
JP2013522368A5 (https=)
JP2015524470A5 (https=)
RU2014102948A (ru) Вакцинная композиция для мукозального введения
JP2008533063A5 (https=)
JP2008534473A (ja) トロンボキサン受容体拮抗薬及びトロンボキサンシンターゼ阻害薬の組み合わせ及びcox−2阻害薬を含む組成物